2014 CRO Quality Benchmarking - Phase I Service Providers

DUBLIN, April 23, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/zp88w2/2013_cro_quality) has announced the addition of the "2014 CRO Quality Benchmarking - Phase I Service Providers" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


In its 5th year, the "CRO Quality Benchmarking" series provides the pharmaceutical industry with a unique resource to evaluate and select CROs, while offering clinical service providers valuable insight into their service quality, their competitors' service quality, and their customers' outsourcing behaviors. This year, Phase I report includes data from 360 unique service evaluations across 23 Phase I service providers.

MAJOR SECTIONS:

1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
2. Service Provider Selection Drivers
3. Service Provider Performance and Scorecards across Attributes
4. Satisfaction, Customer Loyalty, and the Expectations and
5. Service Provider Service Quality Profiles
6. Study Data


Key Topics Covered:

Copyright and Usage Guidelines

Introduction

Methodology

Respondent Demographics
Participant Years of Industry Experience
Participant Geography
Number of Ratings per Company

Major sections

Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
Phase I Leaders, unprompted
Phase I Leaders, Prompted
Received Proposals
Service Provider Usage
Service Provider Cost Perceptions

Service Provider Selection Drivers
Most Important Service Provider Attributes
Service Provider Attributes Gaining Importance

Service Provider Performance and Scorecards across Attributes

Outcome Measures: EPI and Customer Loyalty
Summary of EPI 30 Service Provider Loyalty - A compilation of Overall Satisfaction, Willingness to Recommend, and Likelihood to Use Again

Company Service Quality Profiles
Celerion
Charles River
Covance
ICON
InVentiv Health Clinical
Medpace
PAREXEL
PPD
PRA
PRACS Institute
Quintiles
WCCT

Study Data
Phase I
Phase I Leaders, unprompted
Phase I Leaders, Prompted
Received Proposals
Most Important Service Provider Attributes
Service Provider Attributes Gaining Importance
Service Provider Usage
Service Provider Preference
Best Service Provider at Differentiation
Service Provider Cost Experience
Service Provider Cost Experience by users of past 18 months
Summary of EPI
Service Provider Loyalty

Service Provider Loyalty - A compilation of Overall Satisfaction, Willingness to Recommend, and Likelihood to Use Again
Overall Satisfaction with Service Providers
Willingness to Recommend Service Providers
Likelihood to Use Service Providers Again

Service Providers Drill-downs
CEDRA
Celerion
Charles River
Chiltern
Covance
DaVita
DCRI-Duke
ICON
INC Research
InVentiv Health Clinical
Medpace
PAREXEL
PPD
PRA
PRACS Institute
Premier Research
Quintiles
Rho
SGS Life Sciences
Siro Clinpharm
Theorem
US Oncology
WCCT

Cross-service provider performance
Access to unique tests, machines, equipment
Access to a broad range of services beyond clinic / volunteer management
Access to patient populations
Data quality
Experience of the Phase I unit's lead investigator
Financial strength/ stability
Local market / Regulatory knowledge
Location of Phase I unit(s) in different global region
Location of Phase I unit(s) within your country
Low cost
Meeting database lock timelines
Meeting first patient / first visit timelines
Meeting overall project timelines
Minimizing change orders
Minimizing staff turnover
Offered innovative solutions
Overall value
Patient/ volunteer recruitment
Positive experience with service provider
Project manager quality
Project team chemistry
Scientific knowledge
Speed of site / Investigator recruitment
Speed of site start-up
Technology for real-time access to data
Therapeutic expertise
Timely access to open bed / clinic space
Timely project communications
Up-front contingency planning, risk management

Trade-Offs

Respondent Demographics
Company Type
Primary Area of Responsibility
Outsourcing Responsibility
Job Title
Recent Activity in Outsourced Activities
Phase Responsibility
Involvement in Clinical Development Process
Years in the Industry
Location
Therapeutic Area


For more information visit http://www.researchandmarkets.com/research/zp88w2/2013_cro_quality

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets